Attempts at generating novel chemistries by genetically manipulating polyketide synthases (PKSs) usually result in no detectable or poor product yield. Understanding processes that drive the evolution ...
CAMBRIDGE, England--(BUSINESS WIRE)-- Biotica announces its consolidation of the polyketide engineering intellectual property (IP) space, via acquisition of IP from Bristol-Myers Squibb Company ...
NeuroVive Pharmaceutical AB extended its drug pipeline by picking up a series of polyketide-based preclinical cyclophilin inhibitors from Biotica Technology Ltd., a UK pioneer of polyketide ...
Video shows the mechanism of action of a polyketide synthase module reported by a University of Michigan research team. A new study solves long-standing mysteries about how bacterial ...
LONDON--(BUSINESS WIRE)--Biotica Technology Limited (Biotica), a privately-held biotechnology company that discovers and develops polyketide therapeutics, today announces the nomination of its drug ...
Investors have known for some time that the GLP-1 receptor agonist class offers tremendous promise for treating the underserved obesity population worldwide, but... Gracell Biotechnologies Inc. stands ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results